GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jul 2, 2014

The Name Game: The Debate over Naming Follow-On Biologics

Should biosimilars have the same nonproprietary name as their reference products?

The Name Game: The Debate over Naming Follow-On Biologics

Eight of the top 10 bestselling drug products are expected to be biologics by 2016. [© Burlingham - Fotolia.com]

  • There is an ongoing debate over whether biosimilars and interchangeable biologics should share the same nonproprietary name as their reference biologics. As patents covering ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

    • Do not put any letters or characters here if you are not a spy program.
    •  

Get GEN Select Access Now



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Ebola Vaccines

When do you think an Ebola vaccine will be available for the general public?